Table 1. Baseline characteristics of subjects.

	RV5		Placebo
	n	(%)	n	(%)
Subjects in population	44		22
Sex
Male	21	(47.7)	9	(40.9)
Female	23	(52.3)	13	(59.1)
Age (Years)
65–70	26	(59.1)	12	(54.5)
71–80	18	(40.9)	10	(45.5)
Mean	70.9		71.4
SD	4.3		5.0
Range	65–80		65–79
Race
Asian	4	(9.1)	2	(9.1)
Black	2	(4.5)	0	(0.0)
White	38	(86.4)	20	(90.9)
Ethnicity
Hispanic or Latino	6	(13.6)	4	(18.2)
Not Hispanic or Latino	38	(86.4)	18	(81.8)

RV5, pentavalent rotavirus vaccine, RotaTeq^®; SD, standard deviation.